Acumen Pharmaceuticals, Inc.

ABOS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$46,832$36,810$30,159$35,627
Short-Term Investments$79,777$106,559$118,989$135,930
Receivables$379$315$376$0
Inventory$0$0$0$159
Other Curr. Assets$5,165$4,720$5,423$6,590
Total Curr. Assets$132,153$148,404$154,947$178,306
Property Plant & Equip (Net)$288$335$373$339
Goodwill$0$0$0$0
Intangibles$30$50$56$0
Long-Term Investments$9,443$22,797$48,795$59,968
Tax Assets$0$0$0$0
Other NC Assets$307$311$307$379
Total NC Assets$10,068$23,493$49,531$60,686
Other Assets$0$0$0$0
Total Assets$142,221$171,897$204,478$238,992
Liabilities
Payables$682$2,103$1,056$5,648
Short-Term Debt$3,744$142$138$133
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$17,530$22,616$18,121$21,826
Total Curr. Liab.$21,956$24,861$19,315$27,607
LT Debt$27,092$29,959$28,862$29,569
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$780$0
Total NC Liab.$27,092$29,959$29,642$29,569
Other Liabilities$0$0$0$0
Cap. Leases$185$219$252$283
Total Liabilities$49,048$54,820$48,957$57,176
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$421,324-$394,873-$353,923-$325,127
AOCI$109$23$15-$48
Other Equity$514,382$511,921$509,423$506,985
Total Equity$93,173$117,077$155,521$181,816
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$142,221$171,897$204,478$238,992
Net Debt-$15,996-$6,709-$1,159-$5,925
Acumen Pharmaceuticals, Inc. (ABOS) Financial Statements & Key Stats | AlphaPilot